Circulating Tumor Dna

The detection of specific genomic alterations in circulating tumor DNA appeared linked to poorer outcomes among women with metastatic breast cancer, according to study results.

In this episode, host Shikha Jain, MD, speaks with Aparna Parikh, MD, about cancer and GI malignancies in the global health space, circulating tumor DNA in the field of oncology and more.

Focused ultrasound could provide clinicians a safer alternative in diagnosing, monitoring and treating patients with brain tumors compared with biopsy, according to findings published in npj Precision Oncology.

Arielle J. Medford, MD, is working diligently to further refine individualized treatment for patients with breast cancer with the use of circulating tumor DNA and genomics at large.

In this video, Rachna T. Shroff, MD, MS, discusses data from the CIRCULATE and COBRA studies, which evaluated the role of circulating tumor DNA in guiding treatment decisions for patients with colon cancer.

Circulating tumor DNA analyses can be used as an early marker of immunotherapy response, according to data published in Nature Medicine.

In this video, Stephen M. Ansell, MD, PhD, discusses research presented at ASH Annual Meeting and Exposition on circulating tumor DNA.

Circulating tumor DNA did not successfully predict whether patients with resected stage II colon cancer would benefit from adjuvant chemotherapy, according to findings presented at ASCO Gastrointestinal Cancers Symposium.

Circulating tumor DNA-based detection of molecular residual disease appeared to be highly prognostic of patient outcomes, according to data presented at ASCO Gastrointestinal Cancers Symposium.